NCT00004050 Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer Status TERMINATED Phase PHASE2
NCT00004043 Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer Status COMPLETED Phase PHASE2
NCT00004029 Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE1
NCT00004026 CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy Status TERMINATED Phase PHASE2
NCT00004014 Liposomal Doxorubicin in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00004001 S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE3
NCT00003903 Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer Status COMPLETED Phase NA
NCT00003871 PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003858 Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence Status WITHDRAWN Phase PHASE2
NCT00003819 Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer Status COMPLETED Phase PHASE1
NCT00003781 Docetaxel in Treating Patients With Stage IV Prostate Cancer Status COMPLETED Phase PHASE2
NCT00003734 Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer Status UNKNOWN Phase PHASE3
NCT00003717 Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00003690 Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00003682 Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE3
NCT00003674 Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer Status COMPLETED Phase PHASE3
NCT00003653 Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer Status COMPLETED Phase PHASE3
NCT00003645 Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence Status TERMINATED Phase PHASE3